1999 | Atan Gross, James M. McDonnell, and Stanley J. Korsmeyer
The BCL-2 family of proteins plays a critical role in regulating apoptosis by controlling mitochondrial function. These proteins are divided into pro-apoptotic and anti-apoptotic members, with the ratio between them determining a cell's susceptibility to death signals. Pro-apoptotic members, such as BAX, BAK, and BID, can trigger mitochondrial dysfunction, leading to the release of cytochrome c, which activates caspases and initiates apoptosis. Anti-apoptotic members, like BCL-2 and BCL-XL, prevent this process by inhibiting pro-apoptotic proteins or maintaining mitochondrial integrity.
The BCL-2 family members contain conserved BH domains, with BH3 domains playing a key role in their function. Pro-apoptotic BH3-domain-only proteins, such as BID, can bind to anti-apoptotic proteins like BCL-2, displacing them and promoting apoptosis. Phosphorylation of pro-apoptotic proteins, such as BAD, can regulate their activity by altering their conformation and interactions with anti-apoptotic proteins.
Mitochondrial dysfunction is a central event in apoptosis, involving changes in mitochondrial membrane potential, release of cytochrome c, and activation of caspases. The BCL-2 family members also regulate the permeability transition pore (PTP), which contributes to mitochondrial swelling and cell death. The structural and functional characteristics of BCL-2 family members, including their ability to form dimers and their BH3 domain interactions, are crucial for their roles in apoptosis.
The BCL-2 family members are involved in both mitochondrial-dependent and -independent pathways of apoptosis. Some pathways require mitochondrial function, while others can proceed independently. The BCL-2 family members also play a role in transcriptional regulation, with their expression being controlled by various signaling pathways. Overall, the BCL-2 family members are essential for the regulation of apoptosis, with their activities being tightly controlled by post-translational modifications, conformational changes, and interactions with other proteins.The BCL-2 family of proteins plays a critical role in regulating apoptosis by controlling mitochondrial function. These proteins are divided into pro-apoptotic and anti-apoptotic members, with the ratio between them determining a cell's susceptibility to death signals. Pro-apoptotic members, such as BAX, BAK, and BID, can trigger mitochondrial dysfunction, leading to the release of cytochrome c, which activates caspases and initiates apoptosis. Anti-apoptotic members, like BCL-2 and BCL-XL, prevent this process by inhibiting pro-apoptotic proteins or maintaining mitochondrial integrity.
The BCL-2 family members contain conserved BH domains, with BH3 domains playing a key role in their function. Pro-apoptotic BH3-domain-only proteins, such as BID, can bind to anti-apoptotic proteins like BCL-2, displacing them and promoting apoptosis. Phosphorylation of pro-apoptotic proteins, such as BAD, can regulate their activity by altering their conformation and interactions with anti-apoptotic proteins.
Mitochondrial dysfunction is a central event in apoptosis, involving changes in mitochondrial membrane potential, release of cytochrome c, and activation of caspases. The BCL-2 family members also regulate the permeability transition pore (PTP), which contributes to mitochondrial swelling and cell death. The structural and functional characteristics of BCL-2 family members, including their ability to form dimers and their BH3 domain interactions, are crucial for their roles in apoptosis.
The BCL-2 family members are involved in both mitochondrial-dependent and -independent pathways of apoptosis. Some pathways require mitochondrial function, while others can proceed independently. The BCL-2 family members also play a role in transcriptional regulation, with their expression being controlled by various signaling pathways. Overall, the BCL-2 family members are essential for the regulation of apoptosis, with their activities being tightly controlled by post-translational modifications, conformational changes, and interactions with other proteins.